Lozano-Ortega, Greta
Schermer, Carol R.
Walker, David R.
Szabo, Shelagh M.
Rogula, Basia
Deighton, Alison M.
Gooch, Katherine L.
Campbell, Noll L.
Funding for this research was provided by:
Astellas Pharma Global Development
Article History
First Online: 14 April 2020
Compliance with Ethical Standards
:
: The present study was initiated by Astellas Pharma Global Development, Inc., and funding for the conduct of this study was provided by Astellas Pharma Global Development, Inc.
: Katherine Gooch, Carol Schermer, and David Walker were/are employees of Astellas Pharma Global Development, Inc. at the time of study completion. Greta Lozano-Ortega, Shelagh Szabo, Basia Rogula, and Alison Deighton are employees of Broadstreet Health Economics and Outcomes Research, which received payment from Astellas to conduct this study. Noll Campbell received payment from Astellas for providing consultation services during the conduct of this study.
: Because the Truven MarketScan data are de-identified and are fully Health Insurance Portability and Accountability Act (HIPAA) compliant, and because this study did not involve the collection, use, or transmittal of individually identifiable data, Institutional Review Board review or approval was not required.
: All authors contributed to the study conception and design. Material preparation, and data collection and analysis were performed by Greta-Lozano-Ortega, Carol R. Schermer, David R. Walker, Shelagh M. Szabo, Basia Rogula, Alison M. Deighton, Katherine L. Gooch, and Noll L. Campbell. The first draft of the manuscript was written by Greta-Lozano-Ortega. All authors commented on previous versions of the manuscript, and read and approved the final version.